Skip to main content
. 2020 Aug 29;21(17):6262. doi: 10.3390/ijms21176262

Figure 2.

Figure 2

The effect of glaucoma and AAV-BDNF treatment on the retinal ganglion cell (RGC) number was examined by counting RGCs in 300 μm × 300 μm m fields in the central and peripheral parts of the retina (A). Images from non-treated eye (B) were compared to images from contralateral glaucomatous (C) or glaucomatous and AAV-BDNF treated eyes (D). RGCs were immunolabeled with anti-Brn3a antibody, a widely accepted marker of rodent RGC [31].